The National Cancer Research Institute (NCRI)

• Charity News

Dr Iain Frame appointed CEO of the National Cancer Research Institute

Dr Iain Frame has been appointed as the new CEO of the National Cancer Research Institute (NCRI). Dr Iain Frame has been appointed as the new CEO of the National Cancer Research Institute (NCRI).

3 May 2018

• Health & Medicine

Big data analysis predicts risk of radiotherapy side effects

Analysing big data to predict men’s risk of side effects could help personalise radiotherapy treatment for prostate cancer. Analysing big data to predict men’s risk of side effects could help personalise radiotherapy treatment for prostate cancer.

7 November 2017

• Health & Medicine

Test could diagnose oesophageal cancer 8 years earlier

A new genetic test could help diagnose oesophageal cancer up to 8 years before symptoms appear in people at a high risk of the disease. A new genetic test could help diagnose oesophageal cancer up to 8 years before symptoms appear in people at a high risk of the disease.

6 November 2017

• Health & Medicine

Test could diagnose oesophageal cancer 8 years earlier

A new genetic test could help diagnose oesophageal cancer up to 8 years before symptoms appear in people at a high risk of the disease. A new genetic test could help diagnose oesophageal cancer up to 8 years before symptoms appear in people at a high risk of the disease.

6 November 2017

• Science & Technology
• Health & Medicine

Scientists exploit leaks in blood brain barrier to treat glioblastoma

An ovarian cancer drug can leak through the blood brain barrier to reach brain tumours and could be an effective treatment for glioblastoma. An ovarian cancer drug can leak through the blood brain barrier to reach brain tumours and could be an effective treatment for glioblastoma.

6 November 2017

• Health & Medicine

Low testosterone levels linked to reduced risk of prostate cancer

Men with unusually low amounts of testosterone in their blood are around 20% less likely to develop prostate cancer. Men with unusually low amounts of testosterone in their blood are around 20% less likely to develop prostate cancer.

4 November 2017

• Health & Medicine

More women than men are diagnosed with bowel cancer as an emergency despite extra GP visits

More than a third of women with bowel cancer in England were diagnosed after an emergency hospital visit compared to less than a third of men. More than a third of women with bowel cancer in England were diagnosed after an emergency hospital visit compared to less than a third of men.

3 November 2017

• Health & Medicine

The NCRI partnership launches new five-year strategy to accelerate progress in cancer research

The National Cancer Research Institute (NCRI) launches its new five-year strategy today to accelerate progress in cancer research through collaboration. The National Cancer Research Institute (NCRI) launches its new five-year strategy today to accelerate progress in cancer research through collaboration.

25 April 2017

• Health & Medicine

Researchers find key to drug resistant bowel cancer

Blocking a molecule could bypass bowel cancer’s defence against the drug cetuximab, according to new research presented at the NCRI Cancer Conference. Blocking a molecule could bypass bowel cancer’s defence against the drug cetuximab, according to new research presented at the NCRI Cancer Conference.

9 November 2016

• Science & Technology

Marker for aggressive prostate cancer doubles-up as a drug target

Researchers have discovered that a marker found on aggressive prostate cancer cells could also be used as a way to guide treatments to the cancer. Researchers have discovered that a marker found on aggressive prostate cancer cells could also be used as a way to guide treatments to the cancer.

9 November 2016

• Health & Medicine

One in six women diagnosed with breast cancer have a symptom other than a lump

Around one in six women diagnosed with breast cancer go to their doctor with a symptom other than a lump – the most commonly reported breast cancer symptom. Around one in six women diagnosed with breast cancer go to their doctor with a symptom other than a lump – the most commonly reported breast cancer symptom.

8 November 2016

• Health & Medicine

Gold nanoparticles help deliver lethal one-two punch to cancer

Tagging gold nanoparticles with a small dose of radiation has helped researchers trace the precious metal as it delivers a drug into the heart of cancer cells. Tagging gold nanoparticles with a small dose of radiation has helped researchers trace the precious metal as it delivers a drug into the heart of cancer cells.

8 November 2016